About this trial
This study is a multi-center, prospective, randomized controlled study. The aim of this study is to compare survival rates and to observe quality of life and nutritional status according to follow-up period in patients who underwent radical gastrectomy for stage 2 or 3 gastric cancer.
Eligibility criteria
Qualifiers
Patients aged 19 years or more
Patients who are diagnosed with pathological stage II or III gastric adenocarcinoma according to the AJCC 8th edition
Patients who can understand all information about the trial and decide for themselves whether to participate in this study
Disqualifiers
Vulnerable patients such as pregnant and intellectual disability
Patients who cannot undergo CT owing to poor kidney function or severe adverse effects
Patients who are already in another study and cannot follow the schedule for this trial
Patients who are diagnosed with a cancer other than gastric cancer within five years before the gastrectomy
Trial design
Treatments tested in this trial
- Computed tomography, Chest X-ray, and blood test
Treatment groups
Sponsors and collaborators
National Cancer Center, Korea
Lead sponsor
Korea Health Industry Development Institute
Collaborator